Prior Auth Required
0346U - Investigational Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / ServiceInvestigational Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with
Procedure / Service Description
responding to immune checkpointinhibitor therapy - or not NASH Investigational 0346U Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with Potential tandem mass spectrometry (LC- MS/MS), ratio, plasma
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.